Sulfonamide anticonvulsant

This page covers all Sulfonamide anticonvulsant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Voltage-gated sodium channels, T-type calcium channels, GABA enhancement, Voltage-gated sodium channels, T-type calcium channels, GABA signaling, Voltage-sensitive sodium channels.

Targets

Voltage-gated sodium channels, T-type calcium channels, GABA enhancement · Voltage-gated sodium channels, T-type calcium channels, GABA signaling · Voltage-sensitive sodium channels

Marketed (2)

• zonisamide high dose group · Eisai Korea Inc. · Neurology
  Zonisamide is a sulfonamide anticonvulsant that reduces neuronal excitability by blocking sodium and calcium channels and enhancing GABAergic inhibition.
• Standard dose zonisamide · Mario Negri Institute for Pharmacological Research · Neurology
  Zonisamide is a sulfonamide anticonvulsant that reduces neuronal excitability by blocking sodium and calcium channels and enhancing GABAergic inhibition.

Phase 3 pipeline (1)

• Placebo zonisamide · Rose Research Center, LLC · Neurology
  Zonisamide is an anticonvulsant that works by blocking voltage-sensitive sodium channels in the brain.